F. UZUN, "Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration," BMC Geriatrics , vol.24, no.1, 2024
UZUN, F. 2024. Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration. BMC Geriatrics , vol.24, no.1 .
UZUN, F., (2024). Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration. BMC Geriatrics , vol.24, no.1.
UZUN, FEYZAHAN. "Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration," BMC Geriatrics , vol.24, no.1, 2024
UZUN, FEYZAHAN. "Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration." BMC Geriatrics , vol.24, no.1, 2024
UZUN, F. (2024) . "Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration." BMC Geriatrics , vol.24, no.1.
@article{article, author={FEYZAHAN UZUN}, title={Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration}, journal={BMC Geriatrics}, year=2024}